
Tadalafil API - Bulk Powder
High-purity tadalafil API for licensed formulators. Ships from India-based GMP-audited facilities with Certificate of Analysis and DMF letter of access. Pharmacopeial grades (USP / EP / BP) available on request.
B2B bulk enquiries only. No online purchase available.
Product specifications
- CAS number
- 171596-29-5
- Grade / Strength
- USP · EP · BP
- Pack sizes
- 1 kg · 5 kg · 25 kg
- Origin
- GMP-audited manufacturer
- For buyers in
- United States (B2B)
- Compliance
- WHO-GMP · EU-GMP · US-FDA registered facility
- ✓Certificate of Analysis (per lot)
- ✓Impurity profile
- ✓Manufacturer's DMF letter of access (under NDA)
- ✓Retest / stability data
- ✓MSDS
All variants (9)
Full SKU reference. Use the selector above to build a quote for a specific variant.
All variants (9)
Full SKU reference. Use the selector above to build a quote for a specific variant.
| SKU | Description | Availability |
|---|---|---|
| TAD-API-USP-1KG | USP grade · 1 kg | Available |
| TAD-API-USP-5KG | USP grade · 5 kg | Available |
| TAD-API-USP-25KG | USP grade · 25 kg | Available |
| TAD-API-EP-1KG | EP grade · 1 kg | Available |
| TAD-API-EP-5KG | EP grade · 5 kg | Available |
| TAD-API-EP-25KG | EP grade · 25 kg | Available |
| TAD-API-BP-1KG | BP grade · 1 kg | Available |
| TAD-API-BP-5KG | BP grade · 5 kg | Available |
| TAD-API-BP-25KG | BP grade · 25 kg | Available |
Request quote
Confirm the SKU, tell us the quantity and destination, and we'll come back with pricing, lead time, and payment terms within one business day.
B2B only. Orders are accepted from licensed pharmaceutical wholesalers, importers, formulators, and manufacturers. Every enquiry passes a compliance review before dispatch.
- ✓ Buyer licence verified before dispatch
- ✓ Wire, LC, or net-30 for verified accounts
- ✓ Full documentation (CoA, GMP, batch records) with every shipment
- ✓ One business-day reply for standard SKUs
Trusted by licensed importers, wholesalers & formulators across the United States
Feedback from procurement and regulatory leads at B2B pharmaceutical buyers who have completed at least one dispatched order.
We've moved three tadalafil API tenders through them in the last year. CoAs match the third-party lab retest every time, and net-30 kicked in on our second PO. Our regulatory team stopped asking questions after the first DMF letter of access came through.
Straightforward B2B relationship. They asked for our wholesale distributor licence upfront, verified it against the state board, and only then shared pricing. Refreshing after dealing with brokers who ship first and worry about compliance later.
Quoted a 25 kg USP-grade lot on a Tuesday, had impurity profile and stability data in our inbox Wednesday morning, wire terms finalized Thursday. Lead time held. This is what the whole industry should look like.
We were sceptical about India-origin API for our 505(b)(2) filing. They walked us through the WHO-GMP audit report, arranged a virtual facility tour with the manufacturer, and matched the reference-listed drug's impurity spec. Passed our internal QA gate first pass.
Tender documentation package was tight - CoPP, BMR excerpt, artwork proofs for our private-label run - all delivered within the window. Their ops team actually understands what a US repackager needs, we didn't have to explain 21 CFR Part 211 to anyone.
Placed a modest first order to test the process. No pressure to upsize, no phantom minimum quantities that magically appeared later. Second order was 4x the first and pricing scaled cleanly. Referred two other formulators in our network.
The compliance-review step slowed us down initially and we pushed back. In hindsight it's exactly why we now trust them - every shipment lands with the right paperwork, no customs holds, no surprise re-testing charges. Predictability is worth the extra 48 hours upfront.
We've moved three tadalafil API tenders through them in the last year. CoAs match the third-party lab retest every time, and net-30 kicked in on our second PO. Our regulatory team stopped asking questions after the first DMF letter of access came through.
Straightforward B2B relationship. They asked for our wholesale distributor licence upfront, verified it against the state board, and only then shared pricing. Refreshing after dealing with brokers who ship first and worry about compliance later.
Quoted a 25 kg USP-grade lot on a Tuesday, had impurity profile and stability data in our inbox Wednesday morning, wire terms finalized Thursday. Lead time held. This is what the whole industry should look like.
We were sceptical about India-origin API for our 505(b)(2) filing. They walked us through the WHO-GMP audit report, arranged a virtual facility tour with the manufacturer, and matched the reference-listed drug's impurity spec. Passed our internal QA gate first pass.
Tender documentation package was tight - CoPP, BMR excerpt, artwork proofs for our private-label run - all delivered within the window. Their ops team actually understands what a US repackager needs, we didn't have to explain 21 CFR Part 211 to anyone.
Placed a modest first order to test the process. No pressure to upsize, no phantom minimum quantities that magically appeared later. Second order was 4x the first and pricing scaled cleanly. Referred two other formulators in our network.
The compliance-review step slowed us down initially and we pushed back. In hindsight it's exactly why we now trust them - every shipment lands with the right paperwork, no customs holds, no surprise re-testing charges. Predictability is worth the extra 48 hours upfront.
Serving licensed pharmaceutical buyers across the US
























